What side effects do patients report with Cosentyx (secukinumab)?
Cosentyx (secukinumab) can cause side effects across several categories, but the most common are generally mild to moderate. In clinical use, common reactions include upper respiratory infections and injection-related or skin-related effects.
Commonly reported side effects include:
- Upper respiratory tract infections (such as cold-like symptoms)
- Headache
- Diarrhea
- Injection-site reactions (for example, redness or pain where the shot was given)
What are the serious side effects to watch for?
Serious side effects can occur, and patients are usually advised to seek medical care urgently if they develop signs of the following:
- Serious infections (including worsening infection symptoms, fever that does not improve, or signs of spreading infection)
- Allergic reactions (for example, trouble breathing, facial or throat swelling, or widespread rash)
- Worsening or new inflammatory bowel disease symptoms (watch for persistent or severe diarrhea, belly pain, or blood/mucus in stool)
Does Cosentyx increase infection risk?
Yes. Blocking interleukin-17 (IL-17) can affect how the immune system responds to infections. Patients on Cosentyx may have a higher chance of infections, particularly upper respiratory infections and sometimes more serious infections.
Clinicians typically screen for active infections before starting and monitor during treatment.
What side effects are associated with injection?
Some people experience local reactions where Cosentyx is injected. These can include:
- Redness
- Pain
- Swelling
- Itching
- Bruising
These symptoms are often temporary, but persistent or severe reactions should be reported to the prescribing clinician.
Can Cosentyx cause infections like fungal infections?
Cosentyx can increase susceptibility to certain infections, including fungal infections. If patients develop symptoms consistent with a fungal infection (for example, persistent yeast infection symptoms), they should contact their healthcare team promptly.
Are there differences in side effects by dose or condition?
Side effects are generally similar across the approved indications (plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis/non-radiographic axial spondyloarthritis). The risk profile may still vary person-to-person, depending on overall health, other immune-related medications, and history of infections.
What should patients tell their doctor before starting Cosentyx?
Before starting, patients typically need to discuss:
- Any current infections or recent infections
- History of recurrent infections or tuberculosis (TB) exposure/testing
- History of inflammatory bowel disease
- All current medications, especially other immune-modulating therapies
These factors help clinicians reduce the risk of infections and monitor for GI issues.
Where can I find more detailed side-effect and labeling information?
DrugPatentWatch.com can be a useful place to track product-related details and references, including links out to labeling or related documentation. See: DrugPatentWatch.com: Cosentyx (secukinumab)